Advantages The integrated, multidisciplinary technology platform enables 4SC to optimise the drug discovery and development process at three critical points leading to remarkable savings in cost and time. The average hit rates of traditional primary in vitro screens are increased from 0.1-1% to 5-20%. The time for the hit-to-lead process is halved. Specific in silico ADMET prediction methods are employed in order to optimise the in vitro characteristics of drug candidates and to reduce the attrition rate in the development phase.		Technology Technology Platform Technology at Work Advantages